2003
DOI: 10.1016/s0022-5223(03)00042-4
|View full text |Cite
|
Sign up to set email alerts
|

Comparative study of microfibrillar collagen hemostat (Colgel) and oxidized cellulose (Surgicel) in high transfusion-risk cardiac surgery

Abstract: In conclusion, the easy application, low cost, and significant blood-loss reduction effect of microfibrillar collagen powder renders this agent attractive for cardiac operations associated with high risk of bleeding.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
34
0

Year Published

2004
2004
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 54 publications
(34 citation statements)
references
References 14 publications
0
34
0
Order By: Relevance
“…For high transfusion risk cardiac surgery patients, including repeat cardiac operations (such as aorta coronary bypass operations or valvular operations), ascending aortic aneurysm repair necessitating deep hypothermic circulatory arrest and ascending aortic grafting without deep hypothermic circulatory arrest Surgicel has been compared with microfibrillar collagen hemostat (Colgel [Laboratorie Interphar, Aubervilliers, France]) in terms of the ability to reduce postoperative bleeding and was found to be superior in terms of reducing postoperative drainage (Table 1) [7]. Microfibrillar collagen is not as good at reducing infection risk as Surgicel [5] and is reported to cause end-organ damage if shed blood containing it is returned to the circulation by either pump suction or cell salvage devices, as it may readily pass through the filters of these devices [8].…”
Section: Microfibrillar Collagen Was Initially Described In 1969mentioning
confidence: 99%
“…For high transfusion risk cardiac surgery patients, including repeat cardiac operations (such as aorta coronary bypass operations or valvular operations), ascending aortic aneurysm repair necessitating deep hypothermic circulatory arrest and ascending aortic grafting without deep hypothermic circulatory arrest Surgicel has been compared with microfibrillar collagen hemostat (Colgel [Laboratorie Interphar, Aubervilliers, France]) in terms of the ability to reduce postoperative bleeding and was found to be superior in terms of reducing postoperative drainage (Table 1) [7]. Microfibrillar collagen is not as good at reducing infection risk as Surgicel [5] and is reported to cause end-organ damage if shed blood containing it is returned to the circulation by either pump suction or cell salvage devices, as it may readily pass through the filters of these devices [8].…”
Section: Microfibrillar Collagen Was Initially Described In 1969mentioning
confidence: 99%
“…Hemostatic materials can be formed by combining one or two coagulation cascades or hemostatic proteins including thrombin [97], collagen [98], chitosan [99, 100], and fibrin [4, 101] as well as non-protein materials such as oxidized cellulose [98, 102] and PEG [102]. These hemostats have been used in various forms for surgical applications including matrix [98, 103], patch [104, 105] or liquid [97, 101].…”
Section: Nanoparticle Incorporated Surgical Materialsmentioning
confidence: 99%
“…Karagiannis and colleagues (2008) reported good outcomes with use of type I collagen in 5 obstetric and 3 gynecologic cases [58]. Use of microfibrillar collagen has shown to reduce blood loss more effectively relative to oxidized regenerated cellulose [59]. One industry-sponsored porcine study found equal efficacy of collagen alone (Ultrafoam, Bard Davol) and gelatin matrix with thrombin (Gelfoam hemostasis kit, Baxter, Deerfield, IL) [60].…”
Section: Comparison To Other Topical Hemostatic Agentsmentioning
confidence: 99%